Related Experiment Video
Updated: Aug 20, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Eating pathology among Black and White smokers
Lisa A P Sánchez-Johnsen1, Marian L Fitzgibbon, Jasjit S Ahluwalia
1Cancer Research Center of Hawai'i, University of Hawai'i-Manoa, 1960 East-West Road, Biomedical Science Building, C-105, Honolulu, HI 96822, USA. lsanchez@crch.hawaii.edu
Abstract:
Among White smokers, many females use smoking as a weight control strategy. Little is known about the relationship between eating pathology and smoking among Black females, and whether smokers who enroll in treatment differ in eating pathology from smokers who decline treatment. We examined eating pathology among Black and White smokers who enrolled in a smoking cessation treatment and those who declined treatment. Participants were 100 Black and 100 White female smokers (ages 18-65) who completed three measures of eating pathology. After controlling for BMI, Whites reported greater levels of overall eating pathology than Blacks [F(1,195)=4.1; p<0.05]. Treatment enrollers reported greater levels of disinhibited eating [F(1,197)=15.0; p<0.001) and hunger awareness [F(1,197)=5.6, p<0.05] than treatment decliners, but did not differ in bulimic symptoms. Status of treatment enrollment accounted for the most variance in disinhibited eating (7%; p<.001) and hunger awareness (2.9%; p<0.05). Results indicate that overall pathological eating behaviors are greater among White than Black smokers. However, once females seek smoking cessation treatment, these ethnic differences are not apparent.
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Amebiasis
